Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
Enrique Hernández-Lemus, Mireya Martínez-García
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J. Cabot, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1579-1579
Open Access | Times Cited: 58
A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 29
Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Kenneth K.W. To, William C. Cho
Current Molecular Pharmacology (2022) Vol. 15, Iss. 7, pp. 895-903
Closed Access | Times Cited: 26
Drug repurposing—an emerging strategy in cancer therapeutics
Khadija Shahab Turabi, Ankita Jaywant Deshmukh, Sayan Paul, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 10, pp. 1139-1158
Closed Access | Times Cited: 26
Computational Biology Helps Understand How Polyploid Giant Cancer Cells Drive Tumor Success
Matheus Correia Casotti, Débora Dummer Meira, Aléxia Stefani Siqueira Zetum, et al.
Genes (2023) Vol. 14, Iss. 4, pp. 801-801
Open Access | Times Cited: 15
Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios
Belén Otero-Carrasco, Esther Ugarte Carro, Lucía Prieto Santamaría, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Integrative Analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence
Youngjun Park, Dominik Heider, Anne-Christin Hauschild
Cancers (2021) Vol. 13, Iss. 13, pp. 3148-3148
Open Access | Times Cited: 27
Drug repurposing for Basal breast cancer subpopulations using modular network signatures
Hiram Coria-Rodríguez, Soledad Ochoa, Guillermo de Anda‐Jáuregui, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107902-107902
Closed Access | Times Cited: 8
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
Shipra Singhal, Priyal Maheshwari, Praveen Thaggikuppe Krishnamurthy, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 15, pp. 2726-2756
Closed Access | Times Cited: 13
Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis
Mina Mirian, Amirali Hariri, Mahtasadat Yadollahi, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1578-1578
Open Access | Times Cited: 13
A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
Izamary Delgado-Waldo, Carlos Contreras-Romero, Sandra Salazar-Aguilar, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells
Supusson Pengnam, Purin Charoensuksai, Boon‐ek Yingyongnarongkul, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1196-1196
Open Access | Times Cited: 10
Screening of GPCR drugs for repurposing in breast cancer
Noor Mazin Abdulkareem, Raksha Bhat, Reid T. Powell, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.
Vishakha Anand Pawar, Anuradha Tyagi, Chaitenya Verma, et al.
PubMed (2023) Vol. 15, Iss. 8, pp. 4984-5006
Closed Access | Times Cited: 6
A drug repurposing method based on inhibition effect on gene regulatory network
Xianbin Li, M Liao, Bing Wang, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4446-4455
Open Access | Times Cited: 4
EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources
M. Saranya, Arockia Xavier Annie Rayan, Geetha Thekkumpurath Varrieth
Journal of Biomedical Informatics (2023) Vol. 147, pp. 104528-104528
Closed Access | Times Cited: 4
Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
Yang Song, Haojun Zhang, Xia Song, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 1, pp. 115-129
Open Access | Times Cited: 1
In silico approaches for drug repurposing in oncology: a scoping review
Bruno Raphael Ribeiro Cavalcante, Raíza Dias Freitas, Leonardo de Oliveira Siquara da Rocha, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Unraveling new avenues in pancreatic cancer treatment: A comprehensive exploration of drug repurposing using transcriptomic data
Naina Sunildutt, Faheem Ahmed, Abdul Rahim Chethikkattuveli Salih, et al.
Computers in Biology and Medicine (2024) Vol. 185, pp. 109481-109481
Closed Access | Times Cited: 1
Drug Repurposing for Hematological Malignancies
Antony Anista Michael, Pavithra Balakrishnan, Thirunavukkarasu Velusamy
(2023), pp. 217-252
Closed Access | Times Cited: 3
Breast Cancer Drug Repurposing a Tool for a Challenging Disease
Jonaid Ahmad Malik, Rafia Jan, Sakeel Ahmed, et al.
IntechOpen eBooks (2022)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top